Inhibition of tumor-specific cytotoxic T-Lymphocyte responses by transforming growth factor β1. - Inge,T.H.; Hoover,S.K.; Susskind,B.M.; Barrett,S.K.; Bear,H.D. (Cancer Res, 1992)